VICC, Incyte collaborate to study cancer therapies
July 9, 2015
Vanderbilt-Ingram Cancer Center (VICC) has entered into a multi-year research support and collaboration agreement with Incyte Corporation. The agreement will support basic and translational research to enable novel therapeutic approaches for patients with cancer. See press release.
%7Cutmcsr%3D(direct)%7Cutmcmd%3D(none)%3B%2B__utmv%3D63624821.-%3B)